Rogier Donders

Dr. Rogier Donders


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2012 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
GVGeertje van de Ven
Geertje van de Ven
IDIrena Draskovic
Irena Draskovic
EAEddy Mm Adang
Eddy Mm Adang
RDRogier Donders
Rogier Donders
APAukje Post
Aukje Post
MVMyrra Jfj Vernooij-Dassen
Myrra Jfj Vernooij-Dassen
The effectiveness and efficiency of nursing-home dementia care are suboptimal: there are high rates of neuropsychiatric symptoms among the residents and work-related stress among the staff. Dementia-care mapping is a person-centred care method that may alleviate both the resident and the staff problems. The main objective of this study is to evaluate the effectiveness and cost-effectiveness of dementia-care mapping in nursing-home dementia care.

29 September 2011 in Critical Care
Verified
Journal Article
Open access
PDF file
HHHieronymus Wh van Hees
Hieronymus Wh van Hees
WSWillem-Jan M Schellekens
Willem-Jan M Schellekens
MLMarianne Linkels
Marianne Linkels
FLFloris Leenders
Floris Leenders
JZJan Zoll
Jan Zoll
LHLeo Ma Heunks
Leo Ma Heunks
Introduction: ICU-acquired muscle weakness commonly occurs in patients with septic shock and is associated with poor outcome. Although atrophy is known to be involved, it is unclear whether ligands in plasma from these patients are responsible for initiating degradation of muscle proteins. The aim of the present study was to investigate if plasma from septic shock patients induces skeletal muscle atrophy and to examine the time course of plasma-induced muscle atrophy during ICU stay. Methods: Plasma was derived from septic shock patients within 24 hours after hospital admission (n = 21) and healthy controls (n = 12). From nine patients with septic shock plasma was additionally derived at two, five and seven days after ICU admission. These plasma samples were added to skeletal myotubes, cultured from murine myoblasts. After incubation for 24 hours, myotubes were harvested and analyzed on myosin content, mRNA expression of E3-ligase and Nuclear Factor Kappa B (NFκB) activity. Plasma samples were analyzed on cytokine concentrations. Results: Myosin content was approximately 25% lower in myotubes exposed to plasma from septic shock patients than in myotubes exposed to plasma from controls (P < 0.01). Furthermore, patient plasma increased expression of E3-ligases Muscle RING Finger protein-1 (MuRF-1) and Muscle Atrophy F-box protein (MAFbx) (P < 0.01), enhanced NFκB activity (P < 0.05) and elevated levels of ubiquitinated myosin in myotubes. Myosin loss was significantly associated with elevated plasma levels of interleukin (IL)-6 in septic shock patients (P < 0.001). Addition of antiIL-6 to septic shock plasma diminished the loss of myosin in exposed myotubes by approximately 25% (P < 0.05). Patient plasma obtained later during ICU stay did not significantly reduce myosin content compared to controls. Conclusions: Plasma from patients with septic shock induces loss of myosin and activates key regulators of proteolysis in skeletal myotubes. IL-6 is an important player in sepsis-induced muscle atrophy in this model. The potential to induce atrophy is strongest in plasma obtained during the early phase of human sepsis.

27 August 2012 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
MHMarloes J Huijbers
Marloes J Huijbers
JSJan Spijker
Jan Spijker
RDRogier Donders
Rogier Donders
ASAnneke Van Schaik
Anneke Van Schaik
POPatricia van Oppen
Patricia van Oppen
ASAnne E M Speckens
Anne E M Speckens
Depression is a common psychiatric disorder characterized by a high rate of relapse and recurrence. The most commonly used strategy to prevent relapse/recurrence is maintenance treatment with antidepressant medication (mADM). Recently, it has been shown that Mindfulness-Based Cognitive Therapy (MBCT) is at least as effective as mADM in reducing the relapse/recurrence risk. However, it is not yet known whether combination treatment of MBCT and mADM is more effective than either of these treatments alone. Given the fact that most patients have a preference for either mADM or for MBCT, the aim of the present study is to answer the following questions. First, what is the effectiveness of MBCT in addition to mADM? Second, how large is the risk of relapse/recurrence in patients withdrawing from mADM after participating in MBCT, compared to those who continue to use mADM after MBCT? Two parallel-group, multi-center randomized controlled trials are conducted. Adult patients with a history of depression (3 or more episodes), currently either in full or partial remission and currently treated with mADM (6 months or longer) are recruited. In the first trial, we compare mADM on its own with mADM plus MBCT. In the second trial, we compare MBCT on its own, including tapering of mADM, with mADM plus MBCT. Follow-up assessments are administered at 3-month intervals for 15 months. Primary outcome is relapse/recurrence. Secondary outcomes are time to, duration and severity of relapse/recurrence, quality of life, personality, several process variables, and incremental cost-effectiveness ratio. Taking into account patient preferences, this study will provide information about a) the clinical and cost-effectiveness of mADM only compared with mADM plus MBCT, in patients with a preference for mADM, and b) the clinical and cost-effectiveness of withdrawing from mADM after MBCT, compared with mADM plus MBCT, in patients with a preference for MBCT. ClinicalTrials.gov: NCT00928980

1 January 2014 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
PJPeter J Jongen
Peter J Jongen
RRRob Ruimschotel
Rob Ruimschotel
MHMarco Heerings
Marco Heerings
AHAstrid Hussaarts
Astrid Hussaarts
LDLotte Duyverman
Lotte Duyverman
LVLeo H Visser
Leo H Visser
For persons with multiple sclerosis (MS) it is important to preserve their autonomy, in spite of increasing disability. A major factor mediating autonomy is self-efficacy. According to the social cognitive theory stressors are crucial determinants of self-efficacy, as well as the interaction with partners.

11 April 2014 in Trials
Verified
Journal Article
Open access
PDF file
TSThomas B Sterenborg
Thomas B Sterenborg
TMTheo P Menting
Theo P Menting
YWYvonne de Waal
Yvonne de Waal
RDRogier Donders
Rogier Donders
KWKimberley E Wever
Kimberley E Wever
MWMichiel C Warlé
Michiel C Warlé
Despite the increasing use of pre- and posthydration protocols and low-osmolar instead of high-osmolar iodine-containing contrast media, the incidence of contrast-induced nephropathy (CIN) is still significant. There is evidence that contrast media cause ischemia-reperfusion injury of the medulla. Remote ischemic preconditioning (RIPC) is a non-invasive, safe, and low-cost method to reduce ischemia-reperfusion injury.